Skip to content
Abierto

Vendor, Lake Clear, NY

Ampersand Biosciences LLC

UEI HLWQXLFM7JR8, CAGE 79VC0

3 awards and $1,684,811 obligated between August 27, 2024 and April 9, 2026, 100% under full and open competition, against 10.3 offers on average where reported. 12 of the awards trace back to a SAM.gov solicitation on this site.

Sells to

Awarding agencies by dollars.

National Institutes of Health$1,684,811

Industries

NAICS on the awards, by dollars.

Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714$1,684,811

How it wins

Awards by competition, set-aside and type.

Full and Open Competition3
Definitive Contract3

Solicitations it won

SAM.gov opportunities whose award USAspending attributes to this vendor.

Awards

Every award in the window, by dollars obligated.

ContractAwarding officeDescribed asObligated
75N93024C00087Definitive Contract, September 24, 2024, Full and Open Competition, 12 offersNational Institutes of Health NiaidNational Institutes of HealthFurther Characterization and Validation of Monoclonal Antibodies to Study RespiratoryNAICS 541714, PSC AN12$1,084,824
75N93025C00018Definitive Contract, May 27, 2025, Full and Open Competition, 6 offersSolicitation National Institutes of Health NiaidNational Institutes of HealthDevelopment of Monoclonal Antibodies to Chemokines in the Ferret Model of Respiratory Disease.NAICS 541714, PSC AN11$599,987
75N93022C00044Definitive Contract, August 27, 2024, Full and Open Competition, 13 offersNational Institutes of Health NiaidNational Institutes of HealthSBIR Topic 107 Reagents for Immunologic Analysis of Non- Mammalian and Underrepresented Mammalian ModelsNAICS 541714, PSC AN12$0
Places of performance
New York
Transactions
5 across 3 awards